PATENT CLAIM ANALYSIS

Application Number: 15903772
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "278000"]

Abstract:
The invention relates to a pharmaceutical composition comprising cis-(E)-4-(3-fluorophenyl)-2′,3′,4′,9′-tetrahydro-N,N-dimethyl-2′-(1-oxo-3-phenyl-2-propenyl)-spiro[cyclohexane-1,1′[1H]-pyrido[3,4-b]indol]-4-amine. The pharmaceutical composition is suitable for topical administration, especially for intravesical administration in the treatment of bladder pain.

Claim (Index 10):
The composition according to  claim 5 , wherein the concentration of the excipient is within the range of from 0.1 to 5.0 wt.-%; preferably 0.5 to 4.0 wt.-%, more preferably 1.0 to 3.0 wt.-%; in each case relative to the total weight of the composition.

Metadata:
- Claim Count in Document: 45.0
- Percentile: 88.0
- Lexical Diversity: 1.36585
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14212088', '15542921', '13052792', '12625328', '14142178']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7474303305936849
- 35 USC 102 Novelty (BERT): 0.5048735377380942
- Combined Prediction Score: 0.7231746513081259
- Mean Citation Score: 180.848598
- Max Citation Score: 217.32132
- Similarity Product: 136.63713280193562

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test